Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD⢠Agents and BCL6 Ligand-Directed Degrader at EHA 2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD⢠Agents and BCL6 Ligand-Directed Degrader at EHA 2025